Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

Enric Domingo, Carme Camps, Pamela J Kaisaki, Marie J Parsons, Dmitri Mouradov, Melissa M Pentony, Seiko Makino, Michelle Palmieri, Robyn L Ward, Nicholas J Hawkins, Peter Gibbs, Hanne Askautrud, Dahmane Oukrif, Haitao Wang, Joe Wood, Evie Tomlinson, Yasmine Bark, Kulvinder Kaur, Elaine C Johnstone, Claire PallesDavid N Church, Marco Novelli, Havard E Danielsen, Jon Sherlock, David Kerr, Rachel Kerr, Oliver Sieber, Jenny C Taylor, Ian Tomlinson

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series'. Together they form a unique fingerprint.

Medicine & Life Sciences